Prestige Consumer Healthcare PBH Income Statement (2010-2026)

NYSE PBH
$48.70 -1.09 (-2.19%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Prestige Consumer Healthcare Quarterly Income Statement

Periods 64 quarters
Latest Mar 2026

Prestige Consumer Healthcare income statement data for the quarter ended Mar 2026. This income statement covers 64 quarters of results from Jun 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue
269.18M276.23M274.47M266.94M277.06M289.27M275.52M285.87M279.31M286.32M282.74M276.99M267.14M283.79M290.32M296.52M249.53M274.11M283.44M
Cost of RevenueCost of Rev
110.17M118.51M119.41M118.07M116.94M128.26M125.12M132.10M124.64M126.30M124.80M125.17M121.12M126.40M129.27M126.51M109.20M122.53M126.08M
Gross Profit
159.01M157.71M155.06M148.86M160.12M161.01M150.40M153.76M154.67M160.02M157.94M151.82M146.02M157.38M161.05M170.01M140.33M151.58M157.37M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Selling, General & AdministrativeSG&A
22.47M32.25M25.98M26.75M26.71M26.44M26.54M27.67M27.69M26.00M26.00M26.46M28.91M26.07M26.18M27.05M28.46M28.04M29.67M
Other Operating ExpensesOther Opex
45.20M46.90M46.48M44.68M46.39M50.19M36.68M407.10M41.79M45.77M45.10M43.20M45.07M46.98M42.91M54.53M40.12M43.87M45.20M
Operating ExpensesOpex
67.67M79.15M72.47M71.44M73.11M76.62M63.22M434.76M69.48M71.77M71.11M69.66M73.98M73.04M69.09M81.58M68.58M71.91M74.88M
Operating IncomeOp. Inc
91.34M78.56M82.59M77.42M87.01M84.38M87.18M-281.00M85.19M88.25M86.83M82.15M72.05M84.34M91.96M88.43M71.76M79.67M82.49M
EBIT
91.34M78.56M82.59M77.42M87.01M84.38M87.18M-281.00M85.19M88.25M86.83M82.15M72.05M84.34M91.96M88.43M71.76M79.67M82.49M
Non-operating items
Non Operating Interest Expenses
17.72M17.61M16.57M13.14M12.28M11.46M
Interest & Investment IncomeInt & Inv Inc
-10.20M
Other Non Operating IncomeOther Non Op Inc.
-14.97M-18.93M-17.10M-16.46M-16.12M-17.79M-19.07M-18.52M-16.48M-17.84M-17.26M-14.83M-13.63M-12.68M-11.81M-14.47M-9.98M-10.54M-20.68M
Non Operating IncomeNon Op. Inc.
-14.97M-18.93M-17.10M-16.46M-16.12M-17.79M-19.07M-18.52M-16.48M-17.84M-17.26M-14.83M-13.63M-12.68M-11.81M-14.47M-9.98M-10.54M-20.68M
Net income details
EBT
76.37M59.63M65.49M60.97M70.90M66.59M68.12M-299.52M68.71M70.42M69.58M67.32M58.41M71.66M80.15M73.96M61.78M69.13M61.81M
Tax ProvisionsTaxes
18.61M14.30M15.28M8.88M15.62M15.57M16.17M-58.97M15.44M16.86M16.53M17.86M9.35M17.29M19.12M23.83M14.31M26.92M15.12M
Profit After TaxPAT
57.76M45.33M51.43M52.85M55.27M51.02M58.92M-253.08M53.28M53.56M60.51M46.42M52.23M59.18M61.03M50.13M52.87M42.87M48.06M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
57.76M45.33M50.22M52.09M55.27M51.02M51.95M-240.55M53.28M53.56M53.05M49.46M49.07M54.38M61.03M50.13M47.47M42.21M46.70M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
57.76M45.33M50.22M52.09M55.27M51.02M51.95M-240.55M53.28M53.56M53.05M49.46M49.07M54.38M61.03M50.13M47.47M42.21M46.70M
Income towards Parent CompanyParent Net Inc
57.76M45.33M50.22M52.09M55.27M51.02M51.95M-240.55M53.28M53.56M53.05M49.46M49.07M54.38M61.03M50.13M47.47M42.21M46.70M
Net Income towards Common StockholdersNet Income
57.76M45.33M50.22M52.09M55.27M51.02M51.95M-240.55M53.28M53.56M53.05M49.46M49.07M54.38M61.03M50.13M47.47M42.21M46.70M
Additional items
EPS (Basic)
1.150.901.001.041.101.021.05-4.821.071.081.070.990.981.101.231.010.960.860.98
EPS (Diluted)
1.140.890.991.021.091.021.04-4.821.061.071.060.990.981.091.221.000.950.860.97
Shares Outstanding
50.14M50.23M50.30M50.26M50.26M49.80M49.69M49.89M49.77M49.69M49.74M49.76M49.89M49.65M49.60M49.70M49.48M49.02M47.88M47.88M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
50.67M50.79M50.94M50.84M50.73M50.27M50.19M49.89M50.20M50.08M50.12M50.18M50.27M50.00M49.99M50.08M49.83M49.26M48.09M48.09M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
50.06M50.10M50.20M50.28M49.76M49.53M49.69M49.69M49.54M49.62M49.65M49.92M49.56M49.41M49.54M49.41M49.21M48.08M47.32M56.21M
EBITDA
91.34M78.56M82.59M77.42M87.01M84.38M87.18M-281.00M85.19M88.25M86.83M82.15M72.05M84.34M91.96M88.43M71.76M79.67M82.49M
Interest ExpensesInt Expense
17.72M17.61M16.57M13.14M12.28M11.46M
Tax Rate
24.37%23.99%23.33%14.56%22.04%23.38%23.73%19.69%22.47%23.94%23.76%26.54%16.00%24.12%23.86%32.22%23.17%38.94%24.46%